Genvor Incorporated (GNVR)

Market Cap	22.38M
Revenue (ttm)	n/a
Net Income	-1.16M
EPS	-0.04
Shares Out	34.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	2,094
Open	0.6500
Previous Close	0.6462
Day's Range	0.6500 - 0.7175
52-Week Range	0.0000 - 3.0000
Beta	939,393.12
RSI	41.65
Earnings Date	May 13, 2026

About Genvor

Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. Genvor Incorporated is based in Henderson, Nevada.

• Industry: Agricultural Inputs
• Sector: Materials
• CEO: Chad Pawlak
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: GNVR